CS Genetics
25 Nov, 2024
Courtesy – CS Genetics
The platform is forecast to expand the reach of single cell genomics to major, underserved segments such as new-to-single cell customers and biopharma – and significantly broaden the use of single cell as a tool for scientific discovery.
In November 2024 CS Genetics launched its SimpleCell™ 3' Gene Expression kits – the company’s first commercial offering designed for accessible and scalable single-cell transcriptomics.
CS Genetics has bases in San Diego, California and at Cambridge Science Park in the UK. The company holds a large global intellectual property estate covering its single cell platform and related reagent, workflow, manufacturing and application technologies.